This Week in Infectious Disease: The Top 5 Articles
Looking for the latest developments in infectious disease? Here are the top stories Contagion covered this week.
Catch up on the newest infectious disease studies, drugs, and interviews in Contagion's wrap-up of our most-clicked stories this week.
Studies suggest young women’s substance use is catching up to men's. Tammy Chung, PhD, examined whether this was exacerbated by the COVID-19 pandemic.
Initially, 28-29% of patients with chronic hepatitis B achieved undetectable virus levels after 24 weeks of treatment with GSK’s bepirovirsen, but this dropped to 9-10% of patients during a phase 2b trial.
The benefits to children of wearing face masks to prevent COVID-19 outweigh potential infectious risks from face touching, according to a study analyzing hand-to-face contact in a simulated school environment.
The intranasal, live-attenuated vaccine CodaVax-RSV was granted FDA Fast Track designation. Clinical trials are expected to launch soon.
Frontier Biotechnologies reported phase 1 trial data for its investigational therapy, FB2001, for patients exposed to the virus.